Results for
""Vindesine""[mesh_terms]

Ileus induced by the combination of vinca alkaloids and posaconazole in a patient with acute lymphoblastic leukemia: a case report and literature review.

Yin-Hua Gong, Yue Li, Ming-Feng Zhao, Xia Xiao, Xiao-Chen Wei

The Journal of international medical research 2023;51(8):3000605231193823

Adjuvant treatment with vindesine for metastatic melanoma: in response to the study of Eigentler et al. (2008).

Kristin Henry, Mary Quigley, Spyros Retsas, Demetrios Pectasides

Melanoma research 2009;19(2):123-4

Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.

Thomas K Eigentler, Peter Radny, Axel Hauschild, Ralf Gutzmer, Ruthild Linse, Claudia Pföhler, Stephan N Wagner, Dirk Schadendorf, Ulf Ellwanger, Claus Garbe

Melanoma research 2008;18(5):353-8

Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.

J Y Douillard, S Cigolari, J L Pujol, J C Soria, P Ruffie, T Le Chevalier, D Brisgand, V Aberola

The oncologist 2001;6 Suppl 1():8-11

Inefficacy of vindesine monotherapy in advanced stage IV malignant melanoma patients previously treated with other chemotherapeutic agents.

S Emmert, M Zutt, H Haenssle, C Neumann, L Kretschmer

Melanoma research 2004;13(3):299-302

Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306.

Yutaka Nishiwaki, Kimio Yoshimura, Kazushige Hayakawa, Satoshi Tsuchiya, Iwao Tsukiyama, Kiyoshi Mori, Mari Saito, Akira Yokoyama, Takashi Ogino, Ikuo Sekine, Nagahiro Saijo, Naoki Ishizuka

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):797-803

OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.

M Colombi, L Baldini, A T Maiolo, C Vener, M L Latargia, A Alietti, A Guffanti

Leukemia & lymphoma 2001;40(1-2):87-94

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.

H Tilly, N Mounier, P Lederlin, J Brière, B Dupriez, C Sebban, A Bosly, P Biron, C Nouvel, R Herbrecht, D Bordessoule, B Coiffier

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1309-15

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.

N Takigawa, Y Segawa, H Ueoka, K Kiura, M Tabata, T Shibayama, I Takata, H Miyamoto, K Eguchi, M Harada

Cancer chemotherapy and pharmacology 2000;46(4):272-8

Validated HILIC-MS/MS assay for determination of vindesine in human plasma: Application to a population pharmacokinetic study.

Rong-Hua Zhu, Wen-Xing Peng, Li-Bo Dai, Ping Xu, Zhi-Ping Jiang, Hua-Lin Cai, Huan-De Li

Journal of pharmaceutical and biomedical analysis 2015;96():31-6

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study.

J B Vermorken, G Zanetta, C F De Oliveira, M E van der Burg, A J Lacave, I Teodorovic, G H Boes, N Colombo

Annals of oncology : official journal of the European Society for Medical Oncology 2002;12(7):967-74

Irinotecan in advanced lung cancer: focus on North American trials.

Corey J Langer

Oncology (Williston Park, N.Y.) 2004;18(7 Suppl 4):17-28

A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).

Harubumi Kato, Teruaki Koike, Hiroto Tada, Yukito Ichinose, Takashi Mori, Ryosuke Tsuchiya, Kanji Nagai

The Journal of thoracic and cardiovascular surgery 2003;125(2):254-60

Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.

Prescrire international 2005;14(75):16-8

Role of gemcitabine in the treatment of advanced and metastatic breast cancer.

Volker Heinemann

Oncology 2003;64(3):191-206